4.8 Article

A large fraction of HLA class I ligands are proteasome-generated spliced peptides

Related references

Note: Only part of the references are listed.
Review Immunology

Targeting cancer-specific mutations by T cell receptor gene therapy

Thomas Blankenstein et al.

CURRENT OPINION IN IMMUNOLOGY (2015)

Article Biochemistry & Molecular Biology

The T210M Substitution in the HLA-a*02:01 gp100 Epitope Strongly Affects Overall Proteasomal Cleavage Site Usage and Antigen Processing

Kathrin Textoris-Taube et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Biochemical Research Methods

Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation

Michal Bassani-Sternberg et al.

MOLECULAR & CELLULAR PROTEOMICS (2015)

Review Multidisciplinary Sciences

Adoptive cell transfer as personalized immunotherapy for human cancer

Steven A. Rosenberg et al.

SCIENCE (2015)

Article Immunology

Proteasome isoforms exhibit only quantitative differences in cleavage and epitope generation

Michele Mishto et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2014)

Article Biochemical Research Methods

Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ

Juergen Cox et al.

MOLECULAR & CELLULAR PROTEOMICS (2014)

Article Multidisciplinary Sciences

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin et al.

NATURE (2014)

Article Multidisciplinary Sciences

Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD)

Geert P. M. Mommen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Review Oncology

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

Pierre G. Coulie et al.

NATURE REVIEWS CANCER (2014)

Article Biochemical Research Methods

Unambiguous Phosphosite Localization using Electron-Transfer/Higher-Energy Collision Dissociation (EThcD)

Christian K. Frese et al.

JOURNAL OF PROTEOME RESEARCH (2013)

Article Biochemical Research Methods

Driving Forces of Proteasome-catalyzed Peptide Splicing in Yeast and Humans

Michele Mishto et al.

MOLECULAR & CELLULAR PROTEOMICS (2012)

Article Multidisciplinary Sciences

An antigenic peptide produced by reverse splicing and double asparagine deamidation

Alexandre Dalet et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Immunology

Immunotherapy for persistent viral infections and associated disease

Sjoerd H. van der Burg et al.

TRENDS IN IMMUNOLOGY (2011)

Article Biochemical Research Methods

The 20S Proteasome Splicing Activity Discovered by SpliceMet

Juliane Liepe et al.

PLOS COMPUTATIONAL BIOLOGY (2010)

Article Immunology

Proteasomes in immune cells: more than peptide producers?

Marcus Groettrup et al.

NATURE REVIEWS IMMUNOLOGY (2010)

Article Immunology

Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry

Andreas O. Weinzierl et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2008)

Article Biochemical Research Methods

Validation of endogenous peptide identifications using a database of tandem mass spectra

Maria Faelth et al.

JOURNAL OF PROTEOME RESEARCH (2008)

Article Biochemistry & Molecular Biology

NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11

Claus Lundegaard et al.

NUCLEIC ACIDS RESEARCH (2008)

Article Multidisciplinary Sciences

An antigen produced by splicing of noncontiguous peptides in the reverse order

Edus H. Warren et al.

SCIENCE (2006)

Article Multidisciplinary Sciences

An antigenic peptide produced by peptide splicing in the proteasome

N Vigneron et al.

SCIENCE (2004)